235 related articles for article (PubMed ID: 9010472)
1. Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue.
Ljubimova JY; Petrovic LM; Wilson SE; Geller SA; Demetriou AA
J Histochem Cytochem; 1997 Jan; 45(1):79-87. PubMed ID: 9010472
[TBL] [Abstract][Full Text] [Related]
2. u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.
Tavian D; De Petro G; Benetti A; Portolani N; Giulini SM; Barlati S
Int J Cancer; 2000 Sep; 87(5):644-9. PubMed ID: 10925356
[TBL] [Abstract][Full Text] [Related]
3. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma.
Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
Hepatology; 1997 Apr; 25(4):862-6. PubMed ID: 9096589
[TBL] [Abstract][Full Text] [Related]
4. Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.
Bozkaya G; Korhan P; Cokaklı M; Erdal E; Sağol O; Karademir S; Korch C; Atabey N
Mol Cancer; 2012 Sep; 11():64. PubMed ID: 22962849
[TBL] [Abstract][Full Text] [Related]
5. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
6. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor and c-met expression in Long-Evans Cinnamon rats with spontaneous hepatitis and hepatoma.
Nakayama N; Kashiwazaki H; Kobayashi N; Hamada JI; Ogiso Y; Itakura Y; Matsumoto K; Nakamura T; Koike T; Kuzumaki N; Takeichi N
Hepatology; 1996 Sep; 24(3):596-602. PubMed ID: 8781331
[TBL] [Abstract][Full Text] [Related]
8. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma.
Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
Hepatology; 1997 Mar; 25(3):619-23. PubMed ID: 9049208
[TBL] [Abstract][Full Text] [Related]
9. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.
Inoue H; Yokoyama F; Kita Y; Yoshiji H; Tsujimoto T; Deguchi A; Nakai S; Morishita A; Uchida N; Masaki T; Watanabe S; Kuriyama S
Int J Mol Med; 2006 May; 17(5):857-64. PubMed ID: 16596271
[TBL] [Abstract][Full Text] [Related]
10. Gene expressions of c-met and hepatocyte growth factor in chronic liver disease and hepatocellular carcinoma.
Noguchi O; Enomoto N; Ikeda T; Kobayashi F; Marumo F; Sato C
J Hepatol; 1996 Mar; 24(3):286-92. PubMed ID: 8778194
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers.
Sakata H; Takayama H; Sharp R; Rubin JS; Merlino G; LaRochelle WJ
Cell Growth Differ; 1996 Nov; 7(11):1513-23. PubMed ID: 8930401
[TBL] [Abstract][Full Text] [Related]
13. Co-expression and regulation of Met and Ron proto-oncogenes in human hepatocellular carcinoma tissues and cell lines.
Chen Q; Seol DW; Carr B; Zarnegar R
Hepatology; 1997 Jul; 26(1):59-66. PubMed ID: 9214452
[TBL] [Abstract][Full Text] [Related]
14. Lack of hepatocyte growth factor receptor (c-met) gene expression in fulminant hepatic failure livers before transplantation.
Ljubimova JY; Petrovic LM; Arkadopoulos N; Blanc P; Geller SA; Demetriou AA
Dig Dis Sci; 1997 Aug; 42(8):1675-80. PubMed ID: 9286233
[TBL] [Abstract][Full Text] [Related]
15. MACC1 suppresses cell apoptosis in hepatocellular carcinoma by targeting the HGF/c-MET/AKT pathway.
Yao Y; Dou C; Lu Z; Zheng X; Liu Q
Cell Physiol Biochem; 2015; 35(3):983-96. PubMed ID: 25660117
[TBL] [Abstract][Full Text] [Related]
16. Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: its specific receptor c-met does.
D'Errico A; Fiorentino M; Ponzetto A; Daikuhara Y; Tsubouchi H; Brechot C; Scoazec JY; Grigioni WF
Hepatology; 1996 Jul; 24(1):60-4. PubMed ID: 8707284
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma.
Daveau M; Scotte M; François A; Coulouarn C; Ros G; Tallet Y; Hiron M; Hellot MF; Salier JP
Mol Carcinog; 2003 Mar; 36(3):130-41. PubMed ID: 12619035
[TBL] [Abstract][Full Text] [Related]
18. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
Chan KL; Guan XY; Ng IO
Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor and c-Met expression in rat and human liver fibrosis.
Cramer T; Schuppan D; Bauer M; Pfander D; Neuhaus P; Herbst H
Liver Int; 2004 Aug; 24(4):335-44. PubMed ID: 15287857
[TBL] [Abstract][Full Text] [Related]
20. Stem cell and hepatocyte proliferation in hepatitis C cirrhosis and hepatocellular carcinoma: transplant implications.
Behnke MK; Reimers M; Fisher RA
Ann Hepatol; 2013 Jan-2014 Feb; 13(1):45-53. PubMed ID: 24378265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
